Compared to the No Malignancy group, patients in the Malignancy group were older and had higher rates of male, CKD, prior heart failure hospitalization, previous stroke, culprit vessel of LMT, higher BNP, and higher serum creatinine levels. This evidence concerns the gene NPPB and heart failure.